Browsing "Journal Papers" by Journal : Journal of thoracic oncology
Showing results 1 to 9 of 9
| Pub Year | | Title | Author(s) |
| 2018 | | OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09) | 이현우 |
| 2018 | | P1.15-14: Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study | 이현우, 정준호, 허재성 |
| 2018 | | P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study | 최진혁 |
| 2018 | | P3.15-18: Comparison of Pain Control Effects and Side Effects Early After VATs Lobectomy Between IV-PCA, Epidural-PCA and On-Q | 정준호, 함석진 |
| 2018 | | P3.CR-32: Amyloid Deposition in Thymic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: A Case Report | 박경주 |
| 2019 | | Pretreatment Risk Factors for Postoperative Pulmonary Complication After Neoadjuvant Concurrent Chemoradiotherapy for NSCLC | 유우식 |
| 2019 | | Quantitative Computed Tomography (CT) Based Texture Analysis: Could We Predict the Future Growth of the Pure Ground Glass Nodules? | 민영기, 박경주, 선주성, 유슬기 |
| 2019 | | The Impact of Systemic Treatment on Brain Metastasis in Patients with Non-Small-Cell Lung Cancer: A Nationwide Population-Based Cohort Study | 이현우 |
| 2023 | | Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial | 최진혁 |
1
